Intraoperative Remifentanil Dosage in Surgery for Adolescent Idiopathic Scoliosis Does Not Increase Postoperative Opioid Consumption When Combined With Epidural Analgesia: A Retrospective Cohort Study.

epidural analgesia hyperalgesia opioid remifentanil scoliosis

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Aug 2021
Historique:
accepted: 22 08 2021
entrez: 27 9 2021
pubmed: 28 9 2021
medline: 28 9 2021
Statut: epublish

Résumé

Background In adults, high-dose remifentanil during surgery has been reported to increase postoperative opioid consumption, but this has not been well documented in children. Multimodal analgesia is recommended in the perioperative period for adolescent idiopathic scoliosis (AIS), but no report has examined opioid consumption under epidural analgesia, which is one of the most common types of analgesia. Aims To investigate the association between intraoperative remifentanil dosage and postoperative opioid consumption in AIS in the setting of combined epidural analgesia for postoperative multimodal analgesia. Methods In this retrospective cohort study, patients aged 10-18 years who underwent surgery for scoliosis and epidural analgesia for postoperative pain between July 2012 and April 2019 were included. The primary endpoint was the association between intraoperative cumulative weight-adjusted remifentanil dosage and logarithmic transformation of cumulative weight-adjusted fentanyl consumption in the intensive care unit (ICU). Nonopioid analgesics were investigated as secondary endpoints. An epidural catheter was inserted by the surgeon intraoperatively, and a local anesthetic was administered at the end of the surgery. Multivariate linear regression analysis with adjustment for confounders was performed for all analyses. Results In total, 142 patients were included, and the median intraoperative remifentanil dosage for all patients was 0.27 (interquartile range, 0.24-0.34) µg/kg/min. No association was observed between cumulative weight-adjusted intraoperative dosage of remifentanil and fentanyl, even after adjusting for potential confounders (slope = -1.25; 95% confidence interval [CI], -4.35 to 1.85; P = 0.43). No association was observed between nonopioid analgesic use and intraoperative remifentanil dosage. Conclusion No association was noted between remifentanil dosage during surgery for AIS and postoperative opioid consumption with epidural analgesia. However, this study has limitations due to its retrospective design; thus, further prospective studies are warranted.

Identifiants

pubmed: 34567901
doi: 10.7759/cureus.17361
pmc: PMC8454257
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e17361

Informations de copyright

Copyright © 2021, Aoki et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Pediatrics. 2016 Apr;137(4):
pubmed: 27009035
Anaesthesia. 2016 Nov;71(11):1347-1362
pubmed: 27734470
Anesth Analg. 1982 Apr;61(4):317-22
pubmed: 7199848
Anesth Analg. 2006 Jun;102(6):1662-7
pubmed: 16717305
Anesth Analg. 1998 Nov;87(5):1186-93
pubmed: 9806706
Anesth Analg. 2003 Sep;97(3):810-815
pubmed: 12933407
Neurosurg Focus. 2009 Oct;27(4):E7
pubmed: 19795956
Global Spine J. 2020 May;10(3):346-352
pubmed: 32313800
Mol Pain. 2017 Jan-Dec;13:1744806917737462
pubmed: 28969472
Eur J Clin Nutr. 2002 Oct;56(10):973-82
pubmed: 12373618
Clin Neurophysiol. 2013 Dec;124(12):2291-316
pubmed: 24055297
Br J Anaesth. 2014 Jun;112(6):991-1004
pubmed: 24829420
Pain Manag Nurs. 2019 Jun;20(3):198-206
pubmed: 31080143
Anesth Analg. 2021 Oct 1;133(4):984-990
pubmed: 33555691
Scoliosis Spinal Disord. 2018 Sep 12;13:17
pubmed: 30214945
Anesth Analg. 2016 Sep;123(3):771-81
pubmed: 27537764
Anesthesiology. 2005 Jul;103(1):147-55
pubmed: 15983467
Anesth Analg. 1999 Oct;89(4 Suppl):1
pubmed: 10511070
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Reg Anesth Pain Med. 2019 Jun;44(6):627-631
pubmed: 30923248
Anesthesiology. 1963 Sep-Oct;24:620-4
pubmed: 14063758
Anesth Analg. 2005 Nov;101(5):1343-1348
pubmed: 16243992
J Anesth. 2004;18(1):18-28
pubmed: 14991471
Paediatr Drugs. 2020 Dec;22(6):575-601
pubmed: 33094437
Am J Cardiovasc Drugs. 2014 Oct;14(5):335-42
pubmed: 24934698

Auteurs

Yoshitaka Aoki (Y)

Department of Anesthesiology and Intensive Care Medicine, Hamamatsu University School of Medicine, Hamamatsu, JPN.

Hiroki Iwata (H)

Department of Anesthesiology and Intensive Care Medicine, Hamamatsu University School of Medicine, Hamamatsu, JPN.

Chieko Akinaga (C)

Department of Anesthesiology and Intensive Care Medicine, Hamamatsu University School of Medicine, Hamamatsu, JPN.

Yuki Shiko (Y)

Clinical Research Center, Chiba University Hospital, Chiba, JPN.

Yohei Kawasaki (Y)

Clinical Research Center, Chiba University Hospital, Chiba, JPN.

Kensuke Kobayashi (K)

Department of Anesthesiology and Intensive Care Medicine, Hamamatsu University School of Medicine, Hamamatsu, JPN.

Hiroki Nozawa (H)

Department of Anesthesiology and Intensive Care Medicine, Hamamatsu University School of Medicine, Hamamatsu, JPN.

Hiroyuki Kinoshita (H)

Department of Anesthesiology, Seirei Mikatahara General Hospital, Hamamatsu, JPN.

Yoshiki Nakajima (Y)

Department of Anesthesiology and Intensive Care Medicine, Hamamatsu University School of Medicine, Hamamatsu, JPN.

Classifications MeSH